Seer, Inc.

Seer, Inc. (SEER) priced its initial public offering on Dec 4, 2020 at $19.00 per share, above its $16.00–$18.00 range, raising $175M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $1.1B. J.P. Morgan was lead-left underwriter, joined by Morgan Stanley, BofA Securities and TD Cowen. Wilson Sonsini advised the company and Davis Polk advised the underwriters.

Seer, Inc. is commercializing the Proteograph Product Suite for researchers, which uses engineered nanoparticle technology to give unbiased, deep access to the proteome. The suite combines consumables, an automation instrument and software for large-scale proteomic profiling in nearly any laboratory.

Status

IPO

Ticker

SEER

Exchange

Nasdaq Global Select

Priced

Dec 4, 2020

IPO price

$19.00

Price range

$16.00–$18.00

Raised

$175M

Market cap at IPO price

$1.1B

First filed

Nov 12, 2020

Underwriters

J.P. Morgan, Morgan Stanley, BofA Securities and TD Cowen

Company counsel

Wilson Sonsini

Underwriters' counsel

Davis Polk

Sector

Industrials & materials

Country / state

CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.